LAMISIL

1%w/w %w/w Cream

GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/121/001

Main Information

Trade NameLAMISIL
Active SubstancesTERBINAFINE HYDROCHLORIDE
Strength1%w/w %w/w
Dosage FormCream
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/121/001

Group Information

ATC CodeD01AE15 Antifungals for systemic use

Status

Authorised/WithdrawnAuthorised
Licence Issued30/09/2016
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may be renewed (B)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back